EPISODE · Jul 31, 2026 · 6 MIN
定价200多万的日本心衰+帕金森iPS细胞疗法落地,但正式进入医保
from 天方烨谈
近日,日本将由iPS(诱导多能干细胞)制备的心肌细胞片产品纳入公共医疗保险体系,这也是继今年5月帕金森治疗产品落地后,日本第二款进入全民医保的iPS再生医疗产品。曾经专属于极少数高净值人群的尖端再生医学,正在通过医保制度的普惠设计,真正走向普通重症患者。
Embed this episode
Ready to play
定价200多万的日本心衰+帕金森iPS细胞疗法落地,但正式进入医保
0:00
6:28
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 天方烨谈?
This episode is 6 minutes long.
When was this 天方烨谈 episode published?
This episode was published on July 31, 2026.
Can I download this 天方烨谈 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!